The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model
Open accessAbstract
Human mesenchymal stem cells (hMSCs) can home to tumor sites and inhibit the growth of tumor cells. Little is known about the underlying molecular mechanisms that link hMSCs to the targeted inhibition of tumor cells. In this study, we investigated the effects of hMSCs on two human hepatoma cell lines (H7402 and HepG2) using an animal transplantation model, a co-culture system and conditioned media from hMSCs. Animal transplantation studies showed that the latent time for tumor formation was prolonged and that the tumor size was smaller when SCID mice were injected with H7402 cells and an equal number of Z3 hMSCs. When co-cultured with Z3 cells, H7402 cell proliferation decreased, apoptosis increased, and the expression of Bcl-2, c-Myc, proliferating cell nuclear antigen (PCNA) and survivin was downregulated. After treatment with conditioned media derived from Z3 hMSC cultures, H4702 cells showed decreased colony-forming ability and decreased proliferation. Immunoblot analysis showed that beta-catenin, Bcl-2, c-Myc, PCNA and survivin expression was downregulated in H7402 and HepG2 cells. Taken together, our findings demonstrate that hMSCs inhibit the malignant phenotypes of the H7402 and HepG2 human liver cancer cell lines, which include proliferation, colony-forming ability and oncogene expression both in vitro and in vivo. Furthermore, our studies provide evidence that the Wnt signaling pathway may have a role in hMSC-mediated targeting and tumor cell inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
WNT and β-catenin signalling: diseases and therapies
Moon, R. T., Kohn, A. D., Ferrari, G. V. D., & Kaykas, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1427 · Cited by 1,763
Mesenchymal Stem Cells and Their Potential as Cardiac Therapeutics
Pittenger, M. F., & Martin, B. J. (2004) · Circulation Research · doi:10.1161/01.res.0000135902.99383.6f · Cited by 1,429
Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1874 · Cited by 1,035
Notch signalling regulates stem cell numbers in vitro and in vivo
Androutsellis-Theotokis, A., Leker, R. R., Soldner, F., Hoeppner, D. J., Ravin, R., Poser, S. W., Rueger, M. A., Bae, S.-K., Kittappa, R., & McKay, R. D. G. (2006) · Nature · doi:10.1038/nature04940 · Cited by 956
Ponte, A. L., Marais, E., Gallay, N., Langonné, A., Delorme, B., Hérault, O., Charbord, P., & Domenech, J. (2007) · STEM CELLS · doi:10.1634/stemcells.2007-0054 · Cited by 947
Studeny, M., Marini, F. C., Dembinski, J. L., Zompetta, C., Cabreira-Hansen, M., Bekele, B. N., Champlin, R. E., & Andreeff, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh299 · Cited by 842
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051921 · Cited by 747
Wnt signaling: is the party in the nucleus?
Willert, K., & Jones, K. A. (2006) · Genes & Development · doi:10.1101/gad.1424006 · Cited by 589
One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues
Prockop, D. J., Gregory, C. A., & Spees, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834138100 · Cited by 416
Expression Profiling and Functional Analysis of Wnt Signaling Mechanisms in Mesenchymal Stem Cells
Etheridge, S. L., Spencer, G. J., Heath, D. J., & Genever, P. G. (2004) · STEM CELLS · doi:10.1634/stemcells.22-5-849 · Cited by 344
Chen, G., Shukeir, N., Potti, A., Sircar, K., Aprikian, A., Goltzman, D., & Rabbani, S. A. (2004) · Cancer · doi:10.1002/cncr.20518 · Cited by 283
Gregory, C. A., Singh, H., Perry, A. S., & Prockop, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300373200 · Cited by 282
Rapid Loss of Intestinal Crypts upon Conditional Deletion of the Wnt/Tcf-4 Target Gene c-Myc
Muncan, V., Sansom, O. J., Tertoolen, L., Phesse, T. J., Begthel, H., Sancho, E., Cole, A. M., Gregorieff, A., de Alboran, I. M., Clevers, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00821-06 · Cited by 248
Menon, L. G., Picinich, S., Koneru, R., Gao, H., Lin, S. Y., Koneru, M., Mayer-Kuckuk, P., Glod, J., & Banerjee, D. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0257 · Cited by 237
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy
Hamada, H., Kobune, M., Nakamura, K., Kawano, Y., Kato, K., Honmou, O., Houkin, K., Matsunaga, T., & Niitsu, Y. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00032.x · Cited by 208
NOTCH Signaling as a Novel Cancer Therapeutic Target
Miele, L., Miao, H., & Nickoloff, B. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777441771 · Cited by 201
Monitoring S phase progression globally and locally using BrdU incorporation in TK+ yeast strains
Lengronne, A. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.7.1433 · Cited by 171
Lindvall, C., Evans, N. C., Zylstra, C. R., Li, Y., Alexander, C. M., & Williams, B. O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607571200 · Cited by 169
Regulated subset of G 1 growth-control genes in response to derepression by the Wnt pathway
Baek, S. H., Kioussi, C., Briata, P., Wang, D., Nguyen, H., Ohgi, K. A., Glass, C. K., Wynshaw-Boris, A. J., Rose, D. W., & Rosenfeld, M. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0330217100 · Cited by 167
Wnt Signaling Regulates the Invasion Capacity of Human Mesenchymal Stem Cells
Neth, P., Karow, M., Egea, V., Hoelters, J., Jochum, M., & Ries, C. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0503 · Cited by 153
APC dosage effects in tumorigenesis and stem cell differentiation
Gaspar, C., & Fodde, R. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041807cg · Cited by 144
Yuan, X., Hu, J., Belladonna, M. L., Black, K. L., & Yu, J. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1682 · Cited by 121
Yang, F., Zeng, Q., Yu, G., Li, H., & Wang, C. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.06.015 · Cited by 106
Yu, J. S., Yuan, X., Liu, G., Zeng, Z., Morris-Irvin, D., & Black, K. L. (2005) · Neurosurgery · doi:10.1093/neurosurgery/57.2.411a · Cited by 104
Raida, M., Heymann, A., Günther, C., & Niederwieser, D. W. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.4.735 · Cited by 98
Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives
Ringdén, O. T. H., & Blanc, K. L. (2005) · Apmis · doi:10.1111/j.1600-0463.2005.apm_336.x · Cited by 70
Zhao, Z., Liao, L., Cao, Y., Jiang, X., & Zhao, R. C. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705062 · Cited by 33
Self-citationKaiser, M., Tiegs, G., & Neuhuber, W. (2003) · Histochemistry and Cell Biology · doi:10.1007/s00418-003-0561-0 · Cited by 22
Renga, M., Pedrazzoli, P., & Siena, S. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg317 · Cited by 22
Mesenchymale Stammzellen des Knochenmarks
Wulf, G. G., Chapuy, B., & Trümper, L. H. P. (2006) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-006-1052-6 · Cited by 19
[Mesenchymal stem cells from bone marrow. Phenotype, aspects of biology, and clinical perspectives].
Wulf, G. G., Chapuy, B., & Trümper, L. H. P. (2006) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · Cited by 19
CARP is a novel caspase recruitment domain containing pro-apoptotic protein
Liu, B., Liu, Y., Chen, J., Wei, Z., Yu, H., Zhen, Y., Lu, L., & Hui, R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00379-0 · Cited by 17
[The use of mesenchymal stromal cells in oncology and cell therapy].
Pommey, S., & Galipeau, J. (2006) · PubMed · Cited by 9
Fagioli, F., Berger, M., del Prever, A. B., Lioji, S., Aglietta, M., Ferrari, S., Picci, P., & Madon, E. (2003) · PubMed · Cited by 6
Research works printed but not linked: 5
- Livraghi T, Meloni F, Frosi A . Treatment with stem cell differentiation stage factors of intermediate-advanced hepatocellular carcinoma: an open randomized clinical trial. Oncol Res 2005; 15:399–408. · doi:10.3727/096504005776449716
- Omuro Y, Matsumoto G, Sasaki T, et al. Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. Bone Marrow Transplant 2003; 31:943–945. · doi:10.1038/sj.bmt.1703932
- Qiao L, Xu ZL, Tan X, et al. Investigation of inhibition of Wnt/β-catenin pathway in breast cancer cells mediated by Dkk-1 released from human mesenchymal stem cells. Prog Biochem Biophys 2007; 34:702–708.
- Joubert A, Bianchi P, Maritz C, et al. Influence of prostaglandin A2 on Bax, Bcl-2 and PCNA expression in MCF-7 cells. Biomed Res 2006; 27:157–162. · doi:10.2220/biomedres.27.157
- Plas E, Carroll VA, Jilch R, et al. Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancer. Cytometry 2001; 46:184–189. · doi:10.1002/cyto.1104
Cited by
Klopp, A. H., Gupta, A., Spaeth, E., Andreeff, M., & Marini, F. (2011) · Stem Cells · doi:10.1002/stem.559 · Cited by 562
Nanocarbons for Biology and Medicine: Sensing, Imaging, and Drug Delivery
Panwar, N., Soehartono, A. M., Chan, K. K., Zeng, S., Xu, G., Qu, J., Coquet, P., Yong, K.-T., & Chen, X. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00099 · Cited by 555
Mesenchymal stem cells: key players in cancer progression
Ridge, S. M., Sullivan, F. J., & Glynn, S. A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0597-8 · Cited by 526
McLean, K., Gong, Y., Choi, Y., Deng, N., Yang, K., Bai, S., Cabrera, L., Keller, E., McCauley, L., Cho, K. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45273 · Cited by 380
Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
Hmadcha, A., Martin-Montalvo, A., Gauthier, B. R., Soria, B., & Capilla-Gonzalez, V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00043 · Cited by 341
Metadata
- Authors
- Qiao, L., Xu, Z., Zhao, T., Zhao, Z., Shi, M., Zhao, R. C., Ye, L., & Zhang, X.
- Venue
- Cell Research
- Published
- 2008-03-25
- Volume
- 18
- Issue
- 4
- Pages
- 500-507
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- OpenAlex
- W2083808914
- Cited by
- 388
- References
- 36
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.